BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25493691)

  • 1. IL-17A expression in HIV-specific CD8 T cells is regulated by IL-4/IL-13 following HIV-1 prime-boost immunization.
    Ravichandran J; Jackson RJ; Trivedi S; Ranasinghe C
    J Interferon Cytokine Res; 2015 Mar; 35(3):176-85. PubMed ID: 25493691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique IL-13Rα2-based HIV-1 vaccine strategy to enhance mucosal immunity, CD8(+) T-cell avidity and protective immunity.
    Ranasinghe C; Trivedi S; Stambas J; Jackson RJ
    Mucosal Immunol; 2013 Nov; 6(6):1068-80. PubMed ID: 23403475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-4 and IL-13 mediated down-regulation of CD8 expression levels can dampen anti-viral CD8⁺ T cell avidity following HIV-1 recombinant pox viral vaccination.
    Wijesundara DK; Jackson RJ; Tscharke DC; Ranasinghe C
    Vaccine; 2013 Sep; 31(41):4548-55. PubMed ID: 23933364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of biomarkers to measure HIV-specific mucosal and systemic CD8(+) T-cell immunity using single cell Fluidigm 48.48 Dynamic arrays.
    Trivedi S; Neeman T; Jackson RJ; Ranasinghe R; Jack C; Ranasinghe C
    Vaccine; 2015 Dec; 33(51):7315-7327. PubMed ID: 26519547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8(+) CTL avidity.
    Ranasinghe C; Ramshaw IA
    Eur J Immunol; 2009 Jul; 39(7):1819-30. PubMed ID: 19582753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy.
    Jackson RJ; Worley M; Trivedi S; Ranasinghe C
    Vaccine; 2014 Sep; 32(43):5703-14. PubMed ID: 25151041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17A induces signal transducers and activators of transcription-6-independent airway mucous cell metaplasia.
    Newcomb DC; Boswell MG; Sherrill TP; Polosukhin VV; Boyd KL; Goleniewska K; Brody SL; Kolls JK; Adler KB; Peebles RS
    Am J Respir Cell Mol Biol; 2013 Jun; 48(6):711-6. PubMed ID: 23392574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Immunization Route, Tissue Microenvironment, and Cytokine Cell Milieu on HIV-Specific CD8+ T Cells Measured Using Fluidigm Dynamic Arrays.
    Trivedi S; Ranasinghe C
    PLoS One; 2015; 10(5):e0126487. PubMed ID: 25946028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different HIV pox viral vector-based vaccines and adjuvants can induce unique antigen presenting cells that modulate CD8 T cell avidity.
    Trivedi S; Jackson RJ; Ranasinghe C
    Virology; 2014 Nov; 468-470():479-489. PubMed ID: 25261870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in T helper 1-related immune responses in BALB/c mice immunized with an HIV-1 gag plasmid combined with a chimeric plasmid encoding interleukin-18 and flagellin.
    Chen YL; Chen YS; Hung YC; Liu PJ; Tasi HY; Ni WF; Hseuh PT; Lin HH
    Microbiol Immunol; 2015 Aug; 59(8):483-94. PubMed ID: 26094825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles.
    Ranasinghe C; Turner SJ; McArthur C; Sutherland DB; Kim JH; Doherty PC; Ramshaw IA
    J Immunol; 2007 Feb; 178(4):2370-9. PubMed ID: 17277143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime-boost immunization of codon optimized HIV-1 CRF01_AE Gag in BCG with recombinant vaccinia virus elicits MHC class I and II immune responses in mice.
    Promkhatkaew D; Pinyosukhee N; Thongdeejaroen W; Teeka J; Wutthinantiwong P; Leangaramgul P; Sawanpanyalert P; Warachit P
    Immunol Invest; 2009; 38(8):762-79. PubMed ID: 19860587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.
    Chege GK; Burgers WA; Stutz H; Meyers AE; Chapman R; Kiravu A; Bunjun R; Shephard EG; Jacobs WR; Rybicki EP; Williamson AL
    J Virol; 2013 May; 87(9):5151-60. PubMed ID: 23449790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8
    Li SS; Kochar NK; Elizaga M; Hay CM; Wilson GJ; Cohen KW; De Rosa SC; Xu R; Ota-Setlik A; Morris D; Finak G; Allen M; Tieu HV; Frank I; Sobieszczyk ME; Hannaman D; Gottardo R; Gilbert PB; Tomaras GD; Corey L; Clarke DK; Egan MA; Eldridge JH; McElrath MJ; Frahm N;
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28931520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming with a recombinant pantothenate auxotroph of Mycobacterium bovis BCG and boosting with MVA elicits HIV-1 Gag specific CD8+ T cells.
    Chapman R; Shephard E; Stutz H; Douglass N; Sambandamurthy V; Garcia I; Ryffel B; Jacobs W; Williamson AL
    PLoS One; 2012; 7(3):e32769. PubMed ID: 22479338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.
    Gherardi MM; Nájera JL; Pérez-Jiménez E; Guerra S; García-Sastre A; Esteban M
    J Virol; 2003 Jun; 77(12):7048-57. PubMed ID: 12768024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.
    Li W; Li S; Hu Y; Tang B; Cui L; He W
    Vaccine; 2008 Jun; 26(26):3282-90. PubMed ID: 18472194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses.
    Huang X; Zhu Q; Huang X; Yang L; Song Y; Zhu P; Zhou P
    Vaccine; 2017 Apr; 35(16):2042-2051. PubMed ID: 28318765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1/PD-L1 blockade can enhance HIV-1 Gag-specific T cell immunity elicited by dendritic cell-directed lentiviral vaccines.
    Dai B; Xiao L; Bryson PD; Fang J; Wang P
    Mol Ther; 2012 Sep; 20(9):1800-9. PubMed ID: 22588271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA prime/MVTT boost regimen with HIV-1 mosaic Gag enhances the potency of antigen-specific immune responses.
    Liu W; Wong YC; Chen SMY; Tang J; Wang H; Cheung AKL; Chen Z
    Vaccine; 2018 Jul; 36(31):4621-4632. PubMed ID: 29961605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.